BMEA (Biomea Fusion) Other Current Liabilities: $0.16 Mil (As of Mar. 2026)


BMEA Biomea Fusion Inc BMEA
30 GF Score
Price $1.32
! 1 Warning Sign
View Full Analysis

What is Biomea Fusion Other Current Liabilities?

Biomea Fusion BMEA 30 Other Current Liabilities is $0.16 Mil as of Mar. 2026. GuruFocus rates BMEA with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Biomea Fusion's other current liabilities for the quarter that ended in Mar. 2026 was $0.16 Mil.

Biomea Fusion's quarterly other current liabilities increased from Sep. 2025 ($0.14 Mil) to Dec. 2025 ($0.17 Mil) but then declined from Dec. 2025 ($0.17 Mil) to Mar. 2026 ($0.16 Mil).

Biomea Fusion's annual other current liabilities increased from Dec. 2023 ($0.19 Mil) to Dec. 2024 ($0.20 Mil) but then declined from Dec. 2024 ($0.20 Mil) to Dec. 2025 ($0.17 Mil).

Biomea Fusion Other Current Liabilities Related Terms

Biomea Fusion Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Biomea Fusion's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomea Fusion Other Current Liabilities Chart

Biomea Fusion Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 0.48 0.64 0.19 0.20 0.17

Biomea Fusion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.21 0.14 0.17 0.16
BMEA
30GF Score
Biomea Fusion Inc BMEA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biomea Fusion Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.16 Mil mean?
Biomea Fusion (BMEA) has a Other Current Liabilities of $0.16 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biomea Fusion.
Is Biomea Fusion's Other Current Liabilities too high?
Biomea Fusion's current Other Current Liabilities is $0.16 Mil. Overall, Biomea Fusion has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biomea Fusion's Other Current Liabilities compare to ANIX and PMN?
Biomea Fusion's Other Current Liabilities of $0.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Biomea Fusion. Biomea Fusion's current Other Current Liabilities is $0.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomea Fusion stock overvalued right now?
Biomea Fusion (BMEA) has a current Other Current Liabilities of $0.16 Mil. The current Other Current Liabilities is $0.16 Mil. Biomea Fusion's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Biomea Fusion (BMEA), the current Other Current Liabilities is $0.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomea Fusion Business Description

Address 1599 Industrial Road, San Carlos, CA, USA, 94070
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
30GF Score

Get the complete analysis for BMEA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price